Singapore markets open in 5 hours 16 minutes

Co-Diagnostics, Inc. (CODX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.12000.0000 (0.00%)
As of 03:39PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 35.03M
Enterprise value -12.14M
Trailing P/E 6.10
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.10
Price/book (mrq)0.45
Enterprise value/revenue 0.08
Enterprise value/EBITDA 0.43

Trading information

Stock price history

Beta (5Y monthly) -0.65
52-week change 3-17.04%
S&P500 52-week change 326.16%
52-week high 31.8900
52-week low 30.9750
50-day moving average 31.1593
200-day moving average 31.1941

Share statistics

Avg vol (3-month) 359.55k
Avg vol (10-day) 354.53k
Shares outstanding 531.28M
Implied shares outstanding 635.2M
Float 830.41M
% held by insiders 12.68%
% held by institutions 115.50%
Shares short (30 Apr 2024) 4454.72k
Short ratio (30 Apr 2024) 47.41
Short % of float (30 Apr 2024) 41.49%
Short % of shares outstanding (30 Apr 2024) 41.45%
Shares short (prior month 28 Mar 2024) 4496.5k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-332.62%

Management effectiveness

Return on assets (ttm)-24.44%
Return on equity (ttm)-35.24%

Income statement

Revenue (ttm)6.81M
Revenue per share (ttm)0.23
Quarterly revenue growth (yoy)153.70%
Gross profit (ttm)N/A
EBITDA -41.48M
Net income avi to common (ttm)-35.33M
Diluted EPS (ttm)-1.2000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)58.55M
Total cash per share (mrq)1.87
Total debt (mrq)2.99M
Total debt/equity (mrq)3.48%
Current ratio (mrq)10.81
Book value per share (mrq)2.75

Cash flow statement

Operating cash flow (ttm)-22.08M
Levered free cash flow (ttm)-9.28M